Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 4/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | CBS | P35520 | 1/20 | 0.54 |
| ▸ | LTA4H | P09960 | 2/20 | 0.52 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.48 |
| ▸ | TYR | P14679 | 1/20 | 0.43 |
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4146590 | 0.90 | PTGS2 (0.65) | PTGS2CYP3A4ACHECBSLTA4H | |
| SCHEMBL24650080 | 0.90 | PTGS2 (0.65) | PTGS2CYP3A4ACHECBSLTA4H | |
| SCHEMBL17341744 | 0.86 | PTGS2 (0.68) | PTGS2CYP3A4ACHECBSLTA4H | |
| Bisnorstriatol SCHEMBL9396838 | 0.83 | PTGS2 (0.77) | PTGS2CYP3A4ACHECBSLTA4H | |
| SCHEMBL2987619 | 0.83 | ACHE (0.60) | PTGS2CYP3A4ACHECBSLTA4H | |
| SCHEMBL13267737 | 0.83 | TNKS2 (0.50) | PTGS2CYP3A4LTA4HTNKS2CA2 | |
| SCHEMBL10149325 | 0.80 | LTA4H (0.74) | PTGS2CYP3A4ACHECBSLTA4H | |
| SCHEMBL7493791 | 0.77 | PTGS2 (0.58) | PTGS2CYP3A4ACHECBSLTA4H | |
| SCHEMBL70008 | 0.77 | PTGS2 (0.86) | PTGS2CYP3A4ACHECBSLTA4H | |
| SCHEMBL23777443 | 0.77 | PTGS2 (0.58) | PTGS2CYP3A4ACHECBSLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7777073-B2 | Topical delivery system for antiaging and skin whitening agents | BIODERM RESEARCH (US) | 2010-08-17 | — | — | US | disclosed |
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | BIODERM RESEARCH (US) | 2009-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090074691-A1 | Topical Delivery System for Antiaging and Skin Whitening Agents | TYR, MMP17, MMP1 | PTGS2 529/4885CYP3A4 1115/4885ACHE 903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.